Amino Acid Hypertonic Solution [EPC]

Amino Acid Hypertonic Solution [EPC] was reported 158 times

Drugs of the Amino Acid Hypertonic Solution [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOPHENYLALANINAEMIA 1 0.0312
1 KERATITIS VIRAL 1 0.0244
2 GENITAL INJURY 1 0.0075
3 OSTEOPOROSIS POSTMENOPAUSAL 1 0.0067
4 GENITAL DISORDER MALE 1 0.0047
5 ANORECTAL INFECTION 1 0.0040
6 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
7 ALLERGY TO ARTHROPOD STING 1 0.0022
8 HERNIA PAIN 1 0.0022
9 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
10 CORNEAL SCAR 1 0.0020
11 BODY FAT DISORDER 1 0.0018
12 TONGUE PARALYSIS 1 0.0014
13 AORTIC DISORDER 1 0.0013
14 URETERIC STENOSIS 1 0.0012
15 POST-TRAUMATIC NECK SYNDROME 1 0.0012
16 GASTRIC DILATATION 2 0.0012
17 GENITAL BURNING SENSATION 1 0.0012
18 BURNS THIRD DEGREE 1 0.0009
19 HYDROCELE 1 0.0009
20 ORCHITIS 1 0.0009
21 EPIDIDYMITIS 1 0.0009
22 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
23 TESTICULAR SWELLING 1 0.0008
24 DACRYOSTENOSIS ACQUIRED 1 0.0008
25 DEAFNESS BILATERAL 1 0.0006
26 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
27 URINARY BLADDER HAEMORRHAGE 1 0.0005
28 VITREOUS DETACHMENT 1 0.0005
29 COLONOSCOPY 1 0.0005
30 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
31 GASTROINTESTINAL ULCER 1 0.0005
32 CORNEAL OEDEMA 1 0.0004
33 ENDODONTIC PROCEDURE 1 0.0004
34 ABDOMINAL RIGIDITY 1 0.0004
35 ELECTRIC SHOCK SENSATION 1 0.0004
36 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
37 TESTICULAR PAIN 1 0.0003
38 SUSPECTED COVID-19 1 0.0003
39 SKIN MASS 2 0.0003
40 WOUND HAEMORRHAGE 1 0.0003
41 HYPERACUSIS 1 0.0003
42 PROSTATOMEGALY 1 0.0003
43 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
44 HYPERPHAGIA 1 0.0003
45 RECURRENT CANCER 1 0.0002
46 TOOTH INJURY 1 0.0002
47 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
48 PERFORMANCE STATUS DECREASED 1 0.0002
49 ERUCTATION 4 0.0002
50 DIZZINESS POSTURAL 2 0.0002
51 TOE AMPUTATION 1 0.0002
52 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
53 FOOD POISONING 1 0.0002
54 CHOKING SENSATION 1 0.0002
55 SCAB 2 0.0002
56 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
57 DECREASED INTEREST 1 0.0002
58 MENISCUS INJURY 1 0.0002
59 NASAL DRYNESS 1 0.0002
60 PHOTOPHOBIA 3 0.0002
61 SWELLING OF EYELID 1 0.0002
62 MULTIPLE INJURIES 1 0.0002
63 PHOTOPSIA 1 0.0002
64 SINUS CONGESTION 2 0.0001
65 FORMICATION 1 0.0001
66 INTENTIONAL UNDERDOSE 1 0.0001
67 BREAST TENDERNESS 1 0.0001
68 RHINITIS 1 0.0001
69 HYPERAESTHESIA 1 0.0001
70 NAIL DISORDER 1 0.0001
71 SPINAL OSTEOARTHRITIS 1 0.0001
72 GASTROINTESTINAL INFECTION 1 0.0001
73 LIP DRY 1 0.0001
74 DIARRHOEA HAEMORRHAGIC 1 0.0001
75 THERAPY CHANGE 1 0.0001
76 BLADDER DISORDER 1 0.0001
77 UPPER LIMB FRACTURE 2 0.0001
78 SPINAL FRACTURE 2 0.0001
79 DRY THROAT 1 0.0001
80 EYE DISCHARGE 1 0.0001
81 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
82 SCRATCH 1 0.0001
83 FULL BLOOD COUNT ABNORMAL 1 0.0001
84 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
85 BREAST PAIN 1 0.0001
86 HALLUCINATION 7 0.0001
87 DECREASED ACTIVITY 1 0.0001
88 SKIN LACERATION 1 0.0001
89 INJECTION SITE NODULE 1 0.0001
90 IMPAIRED DRIVING ABILITY 1 0.0001
91 DERMATITIS CONTACT 1 0.0001
92 CHOLECYSTECTOMY 1 0.0001
93 ACCIDENT 1 0.0001
94 LOCALISED INFECTION 2 0.0001
95 PRESYNCOPE 2 0.0001
96 CYTOPENIA 1 0.0001
97 HAIR COLOUR CHANGES 1 0.0001
98 HYPOPHAGIA 2 0.0001
99 PLATELET COUNT INCREASED 1 0.0001
100 IMMUNE SYSTEM DISORDER 1 0.0001
101 TOOTH INFECTION 1 0.0001
102 FREQUENT BOWEL MOVEMENTS 2 0.0001
103 AKATHISIA 1 0.0001
104 DIVERTICULITIS 2 0.0001
105 DEMENTIA 2 0.0001
106 DEVICE OCCLUSION 1 0.0001
107 PARALYSIS 1 0.0001
108 EYE IRRITATION 4 0.0001
109 HOT FLUSH 5 0.0001
110 ANKLE FRACTURE 1 0.0001
111 DELUSION 1 0.0001
112 THERAPY PARTIAL RESPONDER 1 0.0001
113 PNEUMOTHORAX 1 0.0001
114 CYSTITIS 2 0.0001
115 ABSCESS 1 0.0001
116 BACK DISORDER 1 0.0001
117 MUSCULOSKELETAL DISCOMFORT 1 0.0001
118 ABDOMINAL DISTENSION 6 0.0001
119 ORTHOSTATIC HYPOTENSION 1 0.0001
120 LOCAL SWELLING 1 0.0001
121 RASH MACULAR 2 0.0001
122 GALLBLADDER DISORDER 1 0.0001
123 LEUKOCYTOSIS 1 0.0001
124 OSTEOMYELITIS 1 0.0001
125 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
126 BACTERIAL INFECTION 1 0.0001
127 BLOOD URINE PRESENT 1 0.0001
128 PULMONARY FIBROSIS 1 0.0001
129 HERNIA 1 0.0001
130 PRESCRIBED OVERDOSE 1 0.0001
131 HAEMATOCRIT DECREASED 1 0.0001
132 PRODUCT PHYSICAL ISSUE 1 0.0000
133 FEEDING DISORDER 1 0.0000
134 DRY MOUTH 4 0.0000
135 TASTE DISORDER 1 0.0000
136 DYSKINESIA 2 0.0000
137 NEUTROPHIL COUNT DECREASED 2 0.0000
138 INJECTION SITE WARMTH 1 0.0000
139 POLLAKIURIA 2 0.0000
140 ROAD TRAFFIC ACCIDENT 2 0.0000
141 HALLUCINATION, VISUAL 1 0.0000
142 IMPAIRED WORK ABILITY 1 0.0000
143 POOR QUALITY SLEEP 1 0.0000
144 BALANCE DISORDER 4 0.0000
145 FAECES DISCOLOURED 1 0.0000
146 PRODUCT DISPENSING ERROR 1 0.0000
147 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
148 HEART RATE IRREGULAR 1 0.0000
149 OCULAR HYPERAEMIA 2 0.0000
150 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
151 DRUG INTOLERANCE 4 0.0000
152 ENCEPHALOPATHY 1 0.0000
153 AGEUSIA 1 0.0000
154 DRY EYE 2 0.0000
155 ILLNESS 4 0.0000
156 HAEMATOMA 1 0.0000
157 RASH PRURITIC 2 0.0000
158 CONSTIPATION 8 0.0000
159 ABNORMAL DREAMS 1 0.0000
160 WOUND 1 0.0000
161 BLISTER 2 0.0000
162 EYE PAIN 2 0.0000
163 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
164 FLATULENCE 2 0.0000
165 INTENTIONAL DOSE OMISSION 1 0.0000
166 DYSSTASIA 1 0.0000
167 DYSPHONIA 2 0.0000
168 ASCITES 1 0.0000
169 LABORATORY TEST ABNORMAL 1 0.0000
170 CORONARY ARTERY DISEASE 1 0.0000
171 PLEURAL EFFUSION 2 0.0000
172 SWOLLEN TONGUE 1 0.0000
173 CONTUSION 3 0.0000
174 AMNESIA 2 0.0000
175 EYE DISORDER 1 0.0000
176 DRY SKIN 4 0.0000
177 HYPOTENSION 6 0.0000
178 EYE PRURITUS 1 0.0000
179 SINUSITIS 3 0.0000
180 NIGHTMARE 1 0.0000
181 HYPOXIA 1 0.0000
182 PLATELET COUNT DECREASED 3 0.0000
183 MOBILITY DECREASED 2 0.0000
184 MYELOSUPPRESSION 1 0.0000
185 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
186 PANIC ATTACK 1 0.0000
187 RESTLESSNESS 1 0.0000
188 PRODUCT DOSE OMISSION ISSUE 8 0.0000
189 EYE SWELLING 1 0.0000
190 ASTHMA 3 0.0000
191 INJECTION SITE SWELLING 2 0.0000
192 DIZZINESS 13 0.0000
193 PALPITATIONS 3 0.0000
194 DISORIENTATION 1 0.0000
195 CONFUSIONAL STATE 4 0.0000
196 EXTRA DOSE ADMINISTERED 1 0.0000
197 ABDOMINAL DISCOMFORT 4 0.0000
198 WITHDRAWAL SYNDROME 1 0.0000
199 OSTEOARTHRITIS 1 0.0000
200 PULMONARY OEDEMA 1 0.0000
201 THROAT IRRITATION 1 0.0000
202 NEUTROPENIA 3 0.0000
203 MUSCLE SPASMS 4 0.0000
204 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
205 DECREASED APPETITE 5 0.0000
206 COGNITIVE DISORDER 1 0.0000
207 COUGH 6 0.0000
208 ASTHENIA 8 0.0000
209 COMA 1 0.0000
210 PRODUCTIVE COUGH 1 0.0000
211 MULTIPLE SCLEROSIS 1 0.0000
212 FATIGUE 16 0.0000
213 LUNG DISORDER 1 0.0000
214 ALOPECIA 4 0.0000
215 DYSPEPSIA 2 0.0000
216 DIARRHOEA 13 0.0000
217 CELLULITIS 1 0.0000
218 HAEMOGLOBIN DECREASED 2 0.0000
219 NERVOUSNESS 1 0.0000
220 SPEECH DISORDER 1 0.0000
221 DEPRESSED MOOD 1 0.0000
222 DISTURBANCE IN ATTENTION 1 0.0000
223 OEDEMA 1 0.0000
224 TREATMENT NONCOMPLIANCE 1 0.0000
225 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
226 TREMOR 3 0.0000
227 NECK PAIN 1 0.0000
228 PANCYTOPENIA 1 0.0000
229 OXYGEN SATURATION DECREASED 1 0.0000
230 BACK PAIN 4 0.0000
231 BONE PAIN 1 0.0000
232 SURGERY 1 0.0000
233 NASAL CONGESTION 1 0.0000
234 WHEEZING 1 0.0000
235 IRRITABILITY 1 0.0000
236 THERAPEUTIC RESPONSE DECREASED 1 0.0000
237 VERTIGO 1 0.0000
238 DISCOMFORT 1 0.0000
239 FEELING HOT 1 0.0000
240 INJECTION SITE PAIN 5 0.0000
241 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
242 HEADACHE 10 0.0000
243 GAIT DISTURBANCE 3 0.0000
244 LOSS OF CONSCIOUSNESS 2 0.0000
245 HYPERHIDROSIS 2 0.0000
246 RHINORRHOEA 1 0.0000
247 PRODUCT DOSE OMISSION 1 0.0000
248 INFUSION RELATED REACTION 1 0.0000
249 FALL 5 0.0000
250 INSOMNIA 4 0.0000
251 DEHYDRATION 2 0.0000
252 NEOPLASM MALIGNANT 1 0.0000
253 WEIGHT DECREASED 4 0.0000
254 BURNING SENSATION 1 0.0000
255 HYPERTENSION 3 0.0000
256 THERAPY INTERRUPTED 1 0.0000
257 BRONCHITIS 1 0.0000
258 DYSGEUSIA 1 0.0000
259 EPISTAXIS 1 0.0000
260 HYPOAESTHESIA 2 0.0000
261 INCORRECT DOSE ADMINISTERED 3 0.0000
262 DIABETES MELLITUS 1 0.0000
263 BLOOD PRESSURE INCREASED 2 0.0000
264 PARAESTHESIA 2 0.0000
265 FEELING ABNORMAL 3 0.0000
266 CARDIAC FAILURE 1 0.0000
267 CARDIAC FAILURE CONGESTIVE 1 0.0000
268 DYSPNOEA 7 0.0000
269 PNEUMONIA 4 0.0000
270 URTICARIA 2 0.0000
271 RENAL IMPAIRMENT 1 0.0000
272 MYALGIA 2 0.0000
273 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
274 COVID-19 2 0.0000
275 PAIN 7 0.0000
276 NAUSEA 9 0.0000
277 TACHYCARDIA 1 0.0000
278 GASTROINTESTINAL DISORDER 1 0.0000
279 ADVERSE DRUG REACTION 1 0.0000
280 SUICIDAL IDEATION 1 0.0000
281 ADVERSE EVENT 1 0.0000
282 OROPHARYNGEAL PAIN 1 0.0000
283 CHEST PAIN 2 0.0000
284 PRODUCT USE ISSUE 2 0.0000
285 DRUG INEFFECTIVE 14 0.0000
286 ANXIETY 3 0.0000
287 PULMONARY EMBOLISM 1 0.0000
288 MIGRAINE 1 0.0000
289 PRURITUS 4 0.0000
290 ATRIAL FIBRILLATION 1 0.0000
291 PAIN IN EXTREMITY 3 0.0000
292 HEART RATE INCREASED 1 0.0000
293 CHEST DISCOMFORT 1 0.0000
294 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
295 ABDOMINAL PAIN UPPER 2 0.0000
296 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
297 HAEMORRHAGE 1 0.0000
298 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
299 RASH 4 0.0000
300 MALAISE 4 0.0000
301 INFLUENZA 1 0.0000
302 SEPSIS 1 0.0000
303 MUSCULAR WEAKNESS 1 0.0000
304 ABDOMINAL PAIN 2 0.0000
305 CHILLS 1 0.0000
306 DISEASE PROGRESSION 1 0.0000
307 JOINT SWELLING 1 0.0000
308 OEDEMA PERIPHERAL 1 0.0000
309 VISUAL IMPAIRMENT 1 0.0000
310 OFF LABEL USE 7 0.0000
311 VISION BLURRED 1 0.0000
312 ARTHRALGIA 3 0.0000
313 DEATH 6 0.0000
314 INFECTION 1 0.0000
315 ACUTE KIDNEY INJURY 1 0.0000
316 VOMITING 3 0.0000
317 URINARY TRACT INFECTION 1 0.0000
318 PYREXIA 2 0.0000
319 NASOPHARYNGITIS 1 0.0000
320 HYPERSENSITIVITY 1 0.0000
321 ANAEMIA 1 0.0000
322 SOMNOLENCE 1 0.0000
323 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
324 ERYTHEMA 1 0.0000
325 WEIGHT INCREASED 1 0.0000
326 DEPRESSION 1 0.0000
327 CONDITION AGGRAVATED 1 0.0000